24
22
45 41
31
28 Cover Story 12
Product Launches 31
AN EVENT COVERAGE entitled “Microbioz India witnesses the 10th edition of Analytica Anacon India and India Lab Expo: 2017 at Hitex Exhibition Centre, Hyderabad, India” which discusses the participation of Microbioz India and a brief about the happenings in the event.
Product launch Section covering New ABL Semi-Micro Balances introduced by Adam equipments; YumizenH500, an affordable 6Part Hematology Analyzer by HORIBA and many more.
Laboratory Business
19
Grab interesting business news collected from the world of Laboratory and Technology.
An Interview 17 Last but not the least; enjoy reading an interesting & informative interview conducted by Microbioz India team with Mr Thyagu Valliappa, Executive Director –Sona Valliappa Textiles Pvt. Ltd.
Editor’s Pick
16
Featured article on ‘Imapure™ - Platinum Cured Silicone Tube (Regulatory Market)’ by Ami Polymer Pvt Ltd. I hope you have a good read.
Upcoming Events
46
We have compiled a list of Upcoming Largest Laboratory, Medical & Pharma Events and Trade Shows
08
ear friends and readers, I would like to thank you for your extreme love, support and encouragement throughout all these years. It is with your support only that Microbioz India, in just a short span of time has become a successful name in the list of Laboratory, Healthcare Diagnostics & Pharma Magazine. Recently, Microbioz India team exhibited at some of the leading events of Medical, Pharma & Laboratory like Medicall, Chennai; Pharmalytica Hyderabad, Thailand Lab Expo, Bangkok and analytica Anacon India & India Lab expo with Event Special Editions. Moreover, with your hearty blessings Microbioz India has now media partnered with the world’s largest Laboratory & Medical events around the globe. Pittcon, USA; Achema (Germany), Med-Lab Singapore are to name a few. It is so wonderful to be a part of such exhibitions as we are able to connect & interact with more people, build more trust, develop business relations & penetrate the Laboratory Industry, Medical Diagnostics Market as a whole The October edition is again an another event special edition starting with an EVENT COVERAGE entitled “Microbioz India witnesses the 10th edition of Analytica Anacon India and India Lab Expo: 2017 at Hitex Exhibition Centre, Hyderabad, India ” which discusses the participation of Microbioz India and a brief about the happenings in the event. Further, the magazine contains a Product launch Section covering New ABL Semi-Micro Balances introduced by Adam equipments; YumizenH500, an affordable 6-Part Hematology Analyzer by HORIBA and many more. This is not all, you can also read a featured article on ‘Imapure™ - Platinum Cured Silicone Tube (Regulatory Market)’ by Ami Polymer Pvt Ltd. I hope you have a good read. Last but not the least, enjoy reading an interesting interview conducted by Microbioz India team with Mr Thyagu Valliappa, Executive Director –Sona Valliappa Textiles Pvt. Ltd. Dear friends and readers, I hope you find some value in the magazine. We are always eager to receive your valuable feedback and suggestions as they help us come with better content each time. For any further value addition, please write to us at editor@microbiozindia.com.
Event Coverage
Microbioz India witnesses the 10th edition of Analytica Anacon India and India Lab Expo: 2017 at Hitex Exhibition Center, Hyderabad, India Microbioz India, a leading monthly B2B publication in India catering exclusive to the Laboratory technology, Analysis, Biotechnology and Diagnostic industry, exhibited at the show from 21st to 23rd of September. The whole event was co-located with Pharma Pro and Pack Expo 2017 at Hall 2, in Hitex Exhibition Center, Hyderabad India. The 10th edition of analytica Anacon India and India Lab Expo, the International trade fairs for Laboratory Technology, Analysis, Biotechnology and Diagnostics was held in Hyderabad from September 21 to 23, 2017 at HITEX Exhibition Center in Hyderabad. The exhibition brought internationally renowned manufacturers, laboratory users, consultants and key government officials on one platform to discuss best practices and seek solutions to some of the most pressing challenges related to the industry and research.
The whole event was co-located with Pharma Pro and Pack Expo 2017 at Hall 2, in Hitex Exhibition Center, Hyderabad India.
Microbioz India, a leading monthly B2B publication in India catering exclusive to the Laboratory technology, Analysis, Biotechnology and Diagnostic industry, exhibited at the show from 21st to 23rd of September.
Before the show, Microbioz India also got an opportunity to have an interview with Avisha Desai, Senior Project Director, analytica Anacon India and India Lab Expo which has been published in September issue.
The copies of the Laboratory Special Edition of Microbioz India: September Edition was distributed in large numbers throughout the event. The exhibition provided an opportunity to the participants to connect with global leaders, learn about cutting edge technology, hear about vital research and appreciate the changes the industry is going to witness in near future.
In the interview, she said, “Over the years, the trade fair has grown exponentially and it continues to offer innovative and productive solutions for trade visitors. With this objective, analytica Anacon India and India Lab Expo will see a host of new additions which will made it interactive, informative, and innovative.� India Lab Expo & Analytica Anacon India, year 2017 edition of exhibition addressed complex topics such as Audits and Regulatory Affairs, Data Integrity, Extractable and Leachable among others. The show also had a focus on demystifying the emerging technologies for pharmaceutical laboratories.
12
Event Coverage Apart from these, an effort was made by show organizers for the innovative programs like Live Lab, Live Experiments with Lectures for the visitors, which was the main highlight of the show and helped in making the exhibition informative and knowledge sharing platform. As per the event profile, earlier multinational companies were outsourcing only clinical research services to Indian companies. But today with the ever increasing footmark of this sector and many new domestic entrants in the market, India has very much become the go-to place for companies all across the world. India is their key market for their need of good quality and affordable laboratory instruments and equipments, chemical databases, data analysis, data mining, bio-medical text mining and customized tool development.
It was a great show for Microbioz India as we got an excellent opportunity to meet more than 250 exhibitors including 40 foreign exhibiting companies to meet them under one roof. The show has helped Microbioz India to continuously penetrate the market and make numerous corporate relations with the people of our industry.
But today with the ever increasing footmark of this sector and many new domestic entrants in the market, India has very much become the go-to place for companies all across the world.
These segments are expected to grow by the rate of 20% to 35% till 2025 which makes it attractive for foreign investors where in the Indian Companies get good amount of capital to conduct their R&D to keep on improving their product quality and making it cost-effective as well. This ultimately is helping the economy to grow and prosper at a much faster rate. analytica Anacon India and India Lab Expo highlighted the huge potential in Indian Laboratory technology, analysis and biotechnology market. The fair has positioned itself as the leading industry platform on the Indian subcontinent. It is a global gathering that profits exhibitors and visitors alike – the event stands for profitable new ideas, concrete business transactions and promising collaboration opportunities.
Team Microbioz India at Exhibition Venue: Hitex Exhibition Center, Hyderabad, India
“Last year we had 233 exhibitors from 12 countries. This year we have more than 250 exhibitors, the top international giants from across the globe exhibiting at analytica Anacon India and India Lab Expo. Agilent Technologies India Pvt. Ltd., Ahlstrom Asia Holdings Pte. Ltd., Art Lab Equipments, Perain Elmer, Shimadzu Analytical, Smart Labtech Pvt. Ltd., NETZSCH-Gerätebau GmbH, Spinco Biotech Pvt. Ltd., Waters India Pvt. Ltd etc. are few of the companies exhibiting this year. Global companies from countries like China, Germany, USA, Sweden, South Korea, Switzerland, United Kingdom (UK) are participating in addition to new country pavilions from Japan and Singapore.” Ms Avisha Desai, Senior Project Director, analytica Anacon India and India Lab Expo
14
Editor’s Pick
Imapure™ - Platinum Cured Silicone Tube (Regulatory Market) Imapure™ is manufactured by using PLC controlled latest Extrusion Technology & Advance Grade Platinum Cured Silicone and manufactured &packaged in Clean Room Class of ISO-7, ISO 9001 QMS and ISO 14001 & OHSAS 18001 certified facility.
Imapure™ is platinum cured silicone tubing designed for peristaltic pump and fluid transfer in pharmaceutical and biotech applications. Imapure™ is translucent silicone tubing known for its ultra smooth bore to prevent any
It has Extractable study available upon request and excellent biocompatibility due to inertness to tissues and cells. particle entrapment. It is especially designed to comply with requirements of critical food and pharmaceutical standards of regulatory markets.
Imapure™ is manufactured by using PLC controlled latest Extrusion Technology & Advance Grade Platinum Cured Silicone and manufactured &packaged in Clean Room Class of ISO-7, ISO 9001 QMS and ISO 14001 & OHSAS 18001 certified facility. It is inspected by laser online inspection device to maintain critical dimensional consistency and laser etched for traceability. It is manufactured from NSF certified Platinum Cured Silicone Resin. It complies with FDA 21 CFR, USP Class VI & ISO 10993. It has excellent transparency with no odor and taste. It has Extractable study available upon request and excellent biocompatibility due to inertness to tissues and cells. It is sterilizable by using different techniques like Autoclaving, Ethylene
Oxide and Gamma Radiation.It is also available with FDA compliant color coding for ease of identification and custom dimension, hardness & length size also available. Another most important part of tubing is its Extractable and Leachable studies from TOXIKON Lab, USA can be provided upon request and by signing with NDA procedures. Ami Polymer Pvt. Ltd. 319, Mahesh Industrial Estate, Opp. Silver Park, Mira-Bhayander Road, Mira Road (E), Thane - 401104, Maharashtra. INDIA Tel.: +91 22 28555 107 / 631 / 914 | Cell: +91 86910 13935 Email: mktg@amipolymer.com | Web: www.amipolymer.com
16
An Interview
Interview with Mr Thyagu Valliappa, Executive Director –Sona Valliappa Textiles Pvt. Ltd. We have patented “silk stretch” through National Research Development Corporation (NRDC) and have a joint venture with Central Silk Board, Bangalore, for establishing silk stretch with filature, dupion and spun silk yarns for the first time in India. We created this on a scientific formula against all odds.
MICROBIOZ INDIA: As a fourth generation entrepreneur in your family business how do you see the past helping you at present? Thyagu Valliappa: Throughout its rich history, SONA VALLIAPPA GROUP has always been the pioneer of all kinds of businesses and it has never stopped changing and innovating in all of its endeavors. Every futuristic idea formulated by the visionary founder Sri Karumuthu Thiagarajar Chettiar has turned into business success. The group is also known for taking the lead in the emergence of IT exports in India in the 1980s by housing companies like Texas Instruments in its Sona Towers at Millers Road, Bangalore.
17
MICROBIOZ INDIA: Could you tell us briefly about how your group evolved over the years?
MICROBIOZ INDIA: Has the group changed its focus in its activity to work in new-age industry?
Thyagu Valliappa: Sri Karumuthu Thiagarajar Chettiar started the business in a small way in 1920. With hard work, dedication and commitment he could scale up operations assuring quality products and building relationships with each level in trade. Not surprising that he has been the uncrowned king of the textile industry and in 1972 he was the largest spinner of textile yarn in the world. Over the years, his son-in-law Sri Chockalingam Chettiar established a large base of textile mills in Salem and with his son Sri. C. Valliappa established mills all over Karnataka. The textile mills thereafter grew rapidly under the care of the illustrious sons of C. Valliappa.
Thyagu Valliappa: As a group we started our activities in the field of education, construction, etc that helped us in the textiles operations. At the core was our main interest-TEXTILES. We have been seeing the trends and cycles of business in this industry for almost 100 years. Today Sona Valliappa Group is an organization renowned for original research in textiles and using technology to make variety of fabrics for various end use.
An Interview We have patented “silk stretch� through National Research Development Corporation (NRDC) and have a joint venture with Central Silk Board, Bangalore, for establishing silk stretch with filature, dupion and spun silk yarns for the first time in India. We created this on a scientific formula against all odds. Various research organizations work with us in creating unique garment solutions as required by us. In recent days Sona Valliappa Group has integrated textile manufacturing from yarn to garment making. The special innovation is either fashionable or cost effective products. Today our focus is to create value added products for customers for each of its verticals be it yarn, fabric, garment or home textiles. MICROBIOZ INDIA: At the recent India Lab Expo in Hyderabad September 2017, you were displaying special fabric (garments) for Uniforms/Lab coats /Aprons. That was something different and new for the market. Please tell us more on these products. Thyagu Valliappa: As technology evolves, research also gets a boost and we see a synergy in our efforts to provide value to our customers by using fast paced research, high technology and an adopting/accepting market for the new types of fabrics with enhanced benefits on wear and use of our products. For example we have water repellent, fire retardant, blood resistant, wrinkle free, anti-microbial, stain resistant, anti-fungal, odour resistant, mosquito repellent, oil repellent, crease recovery, anti-fade, anti-sting, ( few more soon) variety of garments that can be adopted as aprons/lab coats/ dresses etc. All the finished products will be sold under the brand SONA MILLER
MICROBIOZ INDIA: That list is quite long and impressive. How do you propose reaching out to the market which seems to be in various industry segments? Thyagu Valliappa: Our Company believes in giving customers a product which they will buy and use it immediately. We trust we have been able to do a bit of analyzing, studying the needs of the consumer and keeping in mind the safety, health and other aspects of the customer. We assure comfort of wear in our garments, uniformity, guarantee of quality, healthy partnership building with trade and consumers, standard pricing, ease of buying using technology and apps, delivery tracker, interest free emi option, door to door delivery. For the key industry segments we will want to work with as many, but to start with they will be the pharma/health sector including labs/clinics/R&D centers/ manufacturing /production/hospitals/ testing centers, hospitality industry, chemical industry, manpower and security providers. (You can reach out to Mr. Thyagu Valliappa or his team through sona@valliappa.com ( refer: article in MICROBIOZ INDIA) when you send them an email.) Their website is www.sonavalliappatextile s.com
18
Laboratory Business
Vinnova, a Swedish agency offer grant for oral cholera vaccines to Hillman Laboratories Hilleman Laboratories is a Delhibased vaccine research organization. The firm is an equal-joint venture between US drug maker Merck & Co Inc and British charitable foundation Wellcome Trust. Hilleman Laboratories, a jointventure partnership between US drug maker MSD and Wellcome Trust has received 6 million krona grant from Vinnova, a Swedish agency that funds innovative projects and India’s Department of Biotechnology to advance research for its oral cholera vaccine HILLCHOL. Besides funding, the project will look at knowledge exchange and transfer of scientists from India and Sweden. The World Health Organisation estimates that there are nearly every year there are roughly 1.3 to 4 million cases Cholera cases globally and cause of nearly 21 000 to 143 000 deaths globally.
Hileman labs said that The OCV developed by Hilleman Labs would make mass vaccination a reality in Cholera endemic zones due to ease of manufacturing and low cost, which would improve vaccine affordability and accessibility.
According to Dr Davinder Gill, CEO Hilleman Labs. “Our partnership with DBT and Vinnova is a step in a new direction. We are gratified by the grant awarded to us, which will help us develop capabilities through crossborder partnerships,” The grant is expected to incentivize advancement of clinical R&D against diseases that disproportionately affect poor countries.
The World Health Organisation estimates that there are nearly every year there are roughly 1.3 to 4 million cases Cholera cases globally and cause of nearly 21 000 to 143 000 deaths globally.
Hillman said cholera continues to be a serious health problem and there is high prevalence of the diseases due to global conflict, natural disasters, poor sanitation and unsafe drinking water. Affordable and low-cost vaccines will help in reducing the burden of disease and contribute to Cholera control efforts. Story source and credit: Economic Times Bureau
Redbrick Molecular Ltd, will partner closely with Universities of Sheffield and Leeds to identify commercially valuable chemicals of interest The company, Redbrick Molecular Ltd, will partner closely with universities to identify commercially valuable chemicals of interest. It will license and manufacture compounds for use in drug discovery R & D. Redbrick will use all profits to support further UK chemistry research via grant funding projects at member institutions. Professor Dave Petley, vice president for research and innovation at the University of Sheffield, said: “Universities are always seeking novel ways to translate research into industry-ready tools. I am delighted that Sheffield is a partner in Redbrick Molecular’s pioneering approach to commercialisation, which is inspirational and offers an innovative way to fund future academic research.”
20
Laboratory Business It's currently in phase 1, and at this year’s ASCO Deciphera posted data showing that in GIST patients shown to harbor a broad range of The company was formed with KIT and PDGFRα mutations, it saw industry input, and will aim to form a disease relationships with control other higher rate of education 85% at institutions as both eight licensors and future weeks in company members. 27 It will sit at the patients, interface between 78% at 12 industrial customers weeks in and universities to 23 patients enable both and 60% collaboration and at 24 knowledge exchange. weeks in Andy Hogben, 15 managing director of patients. Redbrick Molecular, The said: “Redbrick is biotech specifically designed is also to act as a conduit working between academic on small and industrial Deciphera Pharmaceuticals, Nightstar Therapeutics and NuCana raised $300 million total in their molecule research. We focus respective funding rounds. drug on delivering generation chemotherapies for candidates, DCC-3014 and industrial-grade products that are resistant tumors, raising $100 rebastinib, as immuno-oncology attractive to medicinal chemists million, and within the range. kinase, or immunokinase, switch working in research and control inhibitors targeting colony development whilst supporting our Fellow British biotech Nightstar stimulating factor receptor 1, or academic partners to develop Therapeutics, a gene therapy player CSF1R, and the TIE2 kinase, exciting new chemistry.” working on rare retinal diseases, also respectively. Story Source and Credit : Laboratory got off a $75 million IPO, within the Back in June, Deciphera raised $52 News,UK midpoint of the range. million in a series C, building on the After a lackluster biotech IPO $75 million it raised in 2015 during market in 2016 and a slow start to its series B round. this year, public offerings for life sciences have started to take off in Its largest stakeholder had been the second half. Brightstar Associates, which owned nearly 68% of the company. Deciphera has a pipeline of oral drug candidates that include three At the time of its B round, its clinical-stage and two research-stage pipeline was led by altiratinib, which programs. Its lead drug candidate, acts on the MET/TIE2/VEGFR2 DCC-2618, is designed to stop pathways, but that asset no longer mutant or amplified KIT and appears in the company's R&D PDGFRα kinases that drive cancers pipeline and seems to have been such as gastrointestinal stromal canned. Three biotech companies focusing tumors, or GIST. on cancer and eye diseases have collectively raised more than $300 million. Industry and higher education relationship
Kinase inhibitor biotech Deciphera Pharmaceuticals raised $128 million, at the high-end of the range, with British cancer oncology NuCana, which is working on second-
Biotech companies focusing on Cancer and Eyes diseases have collectively raised more than $300 million
22
Laboratory Business Edinburgh, U.K.-based NuCana, meanwhile, had been seeking a top $115 million IPO, but got a little less at $100 million. The cash boost should still be enough to help fund late-phase trials of NuCana’s reformulated cancer candidates, including a version of Eli Lilly’s Gemzar it hopes will supplant the veteran chemotherapy in some indications. The biotech has built its pipeline upon the same phosphoramidate chemistry approach that underpins Gilead’s hepatitis C blockbuster Sovaldi.
Those trials found 90% of patients either maintained or improved their visual acuity in the year after receiving the gene therapy. The biotech was originally spun out of the University of Oxford in 2014, starting life with a £12 million raise from Syncona. It pulled in a further £5 million when it named former Johnson & Johnson VP David Fellows as CEO early in 2015, with a $35 million series B round following later that year. And Nightstar broadened its investor base and raised a further $45 million in a series C round just a few months ago.
The Paypal founder contributed to the $5.5 million series A Peptilogics put together to advance its lead treatment for multidrug-resistant bacterial infections toward an IND. Thiel joined with Stefan Roever, BlueTree Ventures and others to power Peptilogics to the series A. The financing follows the generation of preclinical data Peptilogics says suggest its platform and, in particular, its lead candidate can take out a broad spectrum of resistant bacteria. Those data have put
NuCana has used the approach to add a phosphate group protected by groupings of aryl, ester and amino acids to existing drugs. In doing so, NuCana thinks it has created drugs free from the membrane transport, activation and breakdown issues that render cancers resistant to the products they are based on. The company was down to the last $16 million of its $57 million series B by the end of June, meaning this IPO was a key financial driver for its future, as it eyes later stage tests across a broad range of tumors. And finally Nightstar, which had filed for an $86 million IPO and managed $75 million, will equip the biotech to complete a phase 3 trial of its choroideremia gene therapy and advance two other eye disease candidates through early-stage clinical studies. London-based Nightstar, also known as NightstaRx, is set to move the choroideremia asset into phase 3 in the first half of next year. The therapy, NSR-REP1, is advancing into the 140-patient trial on the strength of data on 32 subjects treated in investigator-sponsored studies.
Peter Thiel (Courtesy of By Dan Taylor [CC BY 2.0])
Peptilogics in a position to work toward filing an IND next year. Story source and Credit: Fierce Biotech
Thiel backs Peptilogics to move antibiotic toward IND Peter Thiel has invested in Peptilogics.
Peptilogics is built on a platform it dubbed eCAP (engineered cationic antibiotic peptide). Researchers at the University of Pittsburgh, including Peptilogics cofounder Jonathan Steckbeck, Ph.D., have worked on eCAPs for years, publishing their results in a series of papers that suggest the peptides kill bacteria including Staphylococcus aureus and Pseudomonas aeruginosa.
24
Pete
Laboratory Business Pittsburgh-based Peptilogics’ peptides kill dormant and growing bacteria by disrupting their cell membranes. This direct, nonlytic mechanism differs from those used
by other antibiotics. That has led to hopes that cationic peptides can fill a gap in the antibacterial arsenal.. Academics have talked up cationic peptides for decades as a new way
to kill bacteria, and some candidates have advanced well past the lab bench. Story source and Credit: Fierce Biotech
Post Event Report
LAB Technology week attracts over 9,165 trade visitors, Thailand lab 2017 18 September 2017, Bangkok Thailand Thailand LAB INTERNATIONAL 2017 attracted over 9,165 trade participants from 60 countries. The next edition is scheduled 12-14 September 2018, at EH 102-103, BITEC, Bangkok, Thailand! “Thailand 4.0” policy. It aims to facilitate important transformations for every industry through the use of modern innovation and technology combined with smart ideas and business connection. Thailand LAB INTERNATIONAL 2017, the International Exhibition and Conference on Laboratory Equipment & Technology, Biotechnology & Life Sciences, Chemical & Safety, has realized the significance of Thailand 4.0. This year, it has successfully created a quality market place for laboratory equipment also showcasing the trends & innovations for laboratory applications and solutions. This also became a platform in exchanging knowledge for Laboratory Equipment and Technology, Life Sciences and Bio Investment, LAB safety and Chemical industry to the Asian region.
Thailand LAB INTERNATIONAL 2017 has welcomed more than 9,165 trade participants from a total of 60 countries. This is the only Thailand lab international event that have an increase in the number of people who attended, which is an increase of 34% or 1,329 participants worldwide. There are no less than 330 leading brands which showcased their products in this exhibition with the space of 10,720 sq.m. After the exhibition, in the upcoming 6 months, the value of the Laboratory equipment industry will increase up to 10% of market value, and total value is estimated to be around 40,000 – 60,000 million Baht after this fair.
September 2018, EH 102-103, BITEC, Bangkok. The tradeshow, again, aims to become one of the leading exhibitions and conferences in Southeast Asia for Analytical and Laboratory Equipment and Technology. The tradeshow will be focusing on Analytical & Testing, Clinical & Diagnostic, Research & Development, Chemical & Safety and Calibration & Metrology. In 2018, we’ll be introducing a new feature to this tradeshow which is the, Medical Lab industry. To secure a space, please visit www.thailandlab.com or call +662 670 0900 ext. 201-206, Email: thailandlab@vnuexhibitionsap.com More than 70% of exhibition space is RESERVED!
Thailand LAB INTERNATIONAL will proceed to its 8th edition on 12-14
28
Product launches
New ABL Semi-Micro Balances introduced by Adam equipments Adam Equipment, a leading manufacturer of scales and balances for professionals worldwide, announces the availability of its new ABL series of semimicro balances in the United Kingdom, parts of Europe, and Latin America. ABL semi-micro balances meet the exacting standards of accuracy and precision for high-tech labs. These fiveplace dual-range balances have capacities up to 220g and readability to 0.01mg, making them ideal for advanced, complex applications. Available in two models, the ABL features a streamlined design and 80mm round pan: ABL 125 has capacities of 42g / 120g and readabilities of 0.01mg / 0.1mg. ABL 225 has capacities of 82g / 220g and readabilities of 0.01mg / 0.1mg. Repetitive sample weighing becomes less cumbersome with ABL’s simple operation.
31
Results are clearly visible on the large, backlit graphic display and can be saved via the RS-232 interface. A built-in database stores up to 99 formulas, including 20 ingredients or steps for each formula. The ABL is well-suited for use in product testing and quality assurance labs that need to meet stringent
ABL balances also offer internal automatic calibration, which the balance user can set to be performed at predetermined times or to compensate for ambient temperature fluctuations. A technical calibration capability allows the balance’s internal weight to be finetuned, ensuring proper functioning. With belowbalance weighing capability, ABL can perform density
standards. ABL provides GLPcompliant printouts with date and time for traceability. For consistent results and exceptional precision, ABL offers selectable digital filtering to minimise the effects of vibrations or other disturbances. Both internal calibration and external calibration are standard on both models, allowing for verification and adjustment of the balance.
determination and specific gravity measurement. Other applications include weighing, parts counting, percentage weighing, checkweighing, dynamic / animal weighing, display hold, accumulation of weight, and formulation.
Product launches Adam Equipment manufactures and distributes a full selection of precision balances and scales for the lab, education, industrial, retail, medical and jewelry markets. The company, founded in 1972, is headquartered in England and has offices in the USA, South Africa, Australia and China. Go to www.adamequipment.com for more information about the company and its range of products and services.
Model SCP-R is a fully robotic system that is equipped with four separate hoppers, each with 40 cassettes, for a total capacity of 160 cassettes. It does not rely upon gravity to feed cassettes into the printer. Instead, a robotic arm positively picks each cassette from the top of the desired stack and places it into the printer.
The Milli-Q HR 7000 series from Millipore Sigma, Billerica, Mass, is a high-throughput water purification system that serves as a uniquely connected and sustainable central pure water solution. With advanced purification technologies, Milli-Q HR 7000 ensures constant water quality and flow rate, while reducing water consumption and running costs. The system’s versatile installation and distribution options enable it to reliably produce up to 13,000 L of pure water daily.
The unit is capable of printing color on white cassettes. After printing, cassettes are deposited onto an output rack on the front of the printer. Up to 7 cassettes can be placed onto the rack at a time. With the included extension tray, output capacity is increased to 17 cassettes. For more Information: http://www.primerahealthcare.com / Story source and credit : http://www.clpmag.com/
The series delivers optimum-quality type 3 water for use in regular laboratory applications and instrument feeds. The system features a large, colored touchscreen to display all details needed for daily operations, including storage levels, dispensing information, water production and quality data, consumables status, and step-by-step instructions for consumables replacement. For more Information http://www.merckmillipore.com Story source and credit : http://www.clpmag.com/
Adam Equipment manufactures and distributes a full selection of precision balances and scales for the lab, education, industrial, retail, medical and jewelry markets. The company, founded in 1972, is headquartered in England and has offices in the USA, South Africa, Australia and China. Go to www.adamequipment.com for more information about the company and its range of products and services. Story source and credit: https://www.labbulletin.com For more Information: www.adamequipment.com
Cassette Printer Suited for Pathology, Histology Labs Primera Technology Inc, Plymouth, Minn, has released its robotic-based auto-loading version of the Signature cassette printer, model SCP-R. The printer is designed for use in pathology and histology labs to print high-resolution text, graphics, and bar codes directly onto tissue cassettes. The unit uses thermal-transfer ink ribbons rather than solvent inkjet or laser ablation. As a result, printing is virtually silent and requires no proprietary cassettes, fume removal systems, or ink tanks.
Water Purification System Boasts Connectivity, Sustainability
Process Ready Ultrasonic Flow meter
38
Product launches
Designed to IP65 standards the Process Atrato ultrasonic flowmeter from Titan Enterprises is built for use in demanding process and control environments. Durably constructed from 316 stainless steel and PEEK, and incorporating proprietary ultrasonic flowmeter technology, the Process Atrato offers reduced cost of ownership compared to existing flow measurement devices used in the process environment. Rated for use up to 65°C and 20Bar the compact Process Atrato is available in 4 models operating over flow ranges from 2ml/min to 15litres/min, featuring an accuracy of ±1% over the whole flow range. Each Process Atrato is calibrated with a pre-set 'K' factor so all meters of the same flow range are fully interchangeable simplifying assembly and set-up procedures for OEM manufacturers looking to integrate the flowmeter into their process and control set-up. Using patented technology that enables it to operate accurately over wide flow ranges, the Process Atrato signal processing system permits flow measurement across the whole Reynolds number range allowing both viscous and non-viscous products to be metered.
41
With over 40 years’ experience in flow meter innovation and manufacture, Titan's company philosophy of "pushing the envelope by trying to do things a little different and better" has resulted in sales of over 250,000 products into 40 countries worldwide and a repeat purchase rate of 95%. Today Titan supplies innovative flow measurement solutions to a broad range of market sectors, including medical, chemical, petrochemical, food and drink, laboratory and pharmaceutical. Story source and credit: https://www.labbulletin.com & Titan
The compact Minichiller is designed as a space saving tower and with a footprint of just 225 x 360 mm the Huber Minichiller takes up less bench space than many laptops. With a temperature range from 25°C to +40°C and cooling capacity of up to 900 watts at 15°C, Minichillers are ideal for cooling reaction blocks, vapour traps, vacuum pump condensers, rotary evaporators or heat exchangers, supplying predictable and correct pressure, flow and temperature to applications resulting in tangible process efficiencies.
Huber presents a new budget-friendly and economically Minichiller range Minichiller – small, robust and cost effective New models with OLÉ controller including USB, RS232 and OLED display Environmentally-friendly, economic cooling solution for Laboratory and Industry Chillers provide high efficiency and precise temperature control Many technical applications depend on a reliable cooling solution. Huber Minichillers are the ideal solution for environmentally friendly and economical cooling in laboratory and industry. There are several air and water cooled models available, with cooling powers from 0.28 to 0,9 kW. Efficient energy management in all Huber chillers ensures low operating costs and a quick return on investment.
Because the Minichiller's internal volume is only 2 litres, it eliminates the risk of flooding in the laboratory. This allows the process to be run unattended further increasing efficiency. The Minichillers are now available with the new OLÉ controller. The units combine state of the art technology with simple operation. OLÉ models are suitable for routine tasks in research and industry and are convincing as practice oriented basic equipment.
Product launches They are equipped with USB and RS232 interfaces as standard and have a bright, large OLED display. A Pt100 sensor connection to display (not control) e.g. the process temperature is available as Option. Story source and credit: https://www.labbulletin.com For more Information: www.huber-online.com
Demonstrating high recovery rates for small polar and non-polar compounds the Porvair SLE plate provides the perfect sample clean-up device for physiological fluids prior to analysis by LC/MS. Story source and credit: https://www.labbulletin.com For more Information: http://www.porvair-sciences.com/
High Recovery Extraction of Analytes from Biological Fluids
AriumÂŽ mini: Ultrapure Water System with Unique Bagtank Technology
The 96-well Supported Liquid Extraction (SLE) microplate from Porvair Sciences is designed for routine, high recovery extraction of analytes from biological fluids. High analyte recovery, free of proteins and phospholipids, is routinely obtainable without the need for offline steps such as protein precipitation using this new plate. The large pore size and high pore volume of the diatomaceous earth inert support in the SLE microplate, combined with a wide working range (pH 1-13), allows the routine separation of viscous aqueous solutions such as blood, plasma and serum.
43
Sartorius presents a new system for laboratories needing low volumes of ultrapure water With ariumÂŽ mini, the laboratory and pharmaceutical equipment supplier Sartorius offers an especially compact ultrapure water system. This newly developed system delivers a flow rate of one liter per minute and is specially designed for ultrapure water requirements of less than 10 liters per day. This space-saving unit with a width of only 28 centimeters (11 inches) easily integrates into nearly any lab environment. Feed water needed to produce ultrapure water is supplied by the 5liter bag integrated on the side of the system. Originally developed for the pharmaceutical industry, this bag is optimal for storing purified water. The closed bagtank system prevents secondary contamination while ensuring consistent long-term water quality. Uncomplicated exchange of the bag also facilitates upkeep of the system and considerably reduces maintenance time compared with conventional tank systems.
The bagtank does not require any hazardous cleaning chemicals, further increasing user safety as a result.
Besides its unique bagtank technology, the system is equipped with a high-resolution, touchactivated color display. Easy-tounderstand icons guide the user intuitively through the menu. The Favorites function automatically stores the volume of ultrapure water last dispensed. This prevents errors during repeated dispensing of identical volumes, helping to increase the reliability and efficiency of lab work procedures. Users can choose between two model versions to suit their individual requirements: The standard version of ariumÂŽ mini is independent of a permanently installed water tap. Water is supplied to this system via the integrated bag, which is filled by a built-in pump. In the process, pretreated water is pumped into the bag automatically and is thus used as feed water for the production of ultrapure water. Story source and credit: https://www.labbulletin.com For more Information: http://www.porvair-sciences.com/
Product launches
Small but Mighty: Merck’s ReadyPlate™ 55 Agar Plates for More Efficient Water and Filterable Beverage Testing Merck’s ReadyPlate™ 55 ready-to-use agar plates offer streamlined, convenient and efficient Sample testing for quality With a diameter of just 55 mm, ReadyPlate™ 55 plates are much smaller than standard 90 mm plates, freeing up valuable space in the incubator while reducing waste. The plates are available in a variety of certified kits which combine the agar plates with matching membranes needed for testing. The plates’ lockable, stackable format increases safety and reduces the risk of cross contamination during handling, transport and incubation. The high fill volume makes positioning and removal of membranes to and from the agar plate easy, reducing the risk of handling mistakes and false positives.
ReadyPlate™ 55 plates can be conveniently stored at room temperature and have a six-to-ninemonth shelf life that reduces the energy and storage space needed for refrigeration. The plates are available in a variety of certified kits which combine the agar plates with matching membranes needed for testing. ReadyPlate™ 55 agar plates and ReadyPlate™ 55 certified kits can help customers to improve their sample testing workflows by increasing efficiency without compromising quality. Story source and credit: https://www.labbulletin.com For more Information: http://www.merckmillipore.com/
HORIBA Yumizen H500, an affordable 6-Part Hematology Evolution in medical science is concomitant with the medical technology and routine blood analyzer counting just 5-parts of the leucocytes is no more the craze.
YumizenH500, an affordable 6-Part Hematology Analyzer has become a choice of the doctors & labs. Apart from the general utility of this modern technology in performing CBC (Complete Blood Count) test, it provides unique parameters of PLCC (Platelet Large Cell Count) and LIC (Large Immature Cells). These parameters are well established through research studies and are of immense value in diagnosis & deciding treatment course of thrombocytopenia and leukemia cases respectively. Currently, YumizenH500 has been installed at all leading medical laboratories across the country. The worldknown Japanese brand has used its patented technology of DHSS (Double Hydrodynamic Sequential System) for counting “White Blood Cells” for better precision and accuracy. The key attractions of the YumizenH500 Blood Analyzer are: An affordable 6-part Hematology Analyzer Just 2 Reagents per analysis 27 Parameters Complete platelet indices including PLCC Customizable Color Print Out Unique Parameters (P-LCC & LIC) for cases of thrombocytopenia & Leukemia Artificial Intelligence System For more information: hematology.hin@horiba.com, register.hin@horiba.com
45
6th to 8th October 2017
5th to 7th October 2017
Mumbai
Ahmedabad
27th to 30th November 2017
Mumbai
14th to 16th December 2017
Nepal
26th Feb to 1st March 2018
USA
5th to 8th February 2018
Dubai, UAE
16th to 18th March 2018
Mumbai
2nd to 4th April 2018
Singapore
19th to 21st April 2018
Chennai
11th to 15th June 2018
Germany
RNI TITLE CODE: UPENG04120